CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
All-trans retinoic acid co-administered with pegylated interferon and ribavirin does not influence viral kinetics in hepatitis C infected patients with previous non-response: Results of the ATRACTION study
DOI 10.1055/s-0031-1295936
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Schuchmann, JM Kittner, JF Schlaak, D Klaas, C Eisenbach, T Berg, C Trautwein, R Günther, S Zeuzem, R Goesseringer, A Ehrlich, K Neumann, D Wachtlin, WO Boecher, PR Galle
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: To assess antiviral potential, safety, and tolerability of all-trans retinoic acid (tretinoin) in combination with peg-IFN alfa–2a and ribavirin in HCV–1 infected patients with prior non-response. Viral kinetics in the initial 12 weeks of treatment were used as the primary endpoint. Method: Randomized, open label, multicenter clinical trial. Patients received either pegIFN (P)/ribavirin (R) plus tretinoi…
Zitieren
Zitierempfehlung
M Schuchmann, JM Kittner, JF Schlaak, D Klaas, C Eisenbach, T Berg, C Trautwein, R Günther, S Zeuzem, R Goesseringer, A Ehrlich, K Neumann, D Wachtlin, WO Boecher, PR Galle (2012) All-trans retinoic acid co-administered with pegylated interferon and ribavirin does not influence viral kinetics in hepatitis C infected patients with previous non-response: Results of the ATRACTION study. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295936
Mit CareLit weiterarbeiten